Current Issue - April 2008, Volume 2, Issue No. 1

1. Herberts P, Malchau H. How outcome studies have changed total hip arthroplasty practices in Sweden. Clin Orthop. 1997; 344:44-60.
2. Ethgen O, Bruyère O, Richy F, et al. Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am. 2004; 86A(5): 963-74.
3. Hozack WJ, Mesa JJ, Carey C, Rothman RH. Relationship between polyethylene wear, pelvic osteolysis, and clinical symptomatology in patients with cementless acetabular components: A framework for decision making. J Arthroplasty. 1996; 11:769-72.
4. Maloney WJ, Galante JO, Anderson M, et al. Fixation, polyethylene wear, and pelvic osteolysis in primary total hip replacement. Clin Orthop. 1999; 369: 157-64.
5. Shih CH, Lee PC, Chen JH, et al. Measurement of polyethylene wear in cementless total hip arthroplasty. J Bone Joint Surg. 1997; 79B: 361-5.
6. Jones LC, Hungerford DS. Cement disease. Clin Orthop. 1987; 225: 192-206.
7. McKellop H, Park SH, Chiesa R. In vivo wear of three types of metal on metal hip prostheses during two decades of use. Clin Orthop. 1996; (329 Suppl), S128-40.
8. Mirra JM, Marder RA, Amstutz HC. The pathology of failed total joint arthroplasty. Clin Orthop. 1982; 170: 175-83.
9. Jiranek WA, Machado M, Jasty M, et al. Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization. J Bone Joint Surg. 1993; 75A: 863-79.
10. Kodaya Y, Revell PA, Al-Saffar N, et al. Bone formation and bone resorption in failed total joint replacements arthroplasties: histomorphometric analysis with histochemical and immunohistochemical technique. J Orthop Res. 1996; 14: 473-82.
11. Shanbhag AS, Jacobs JJ, Black J, et al. Cellular mediators secreted by interfacial membranes obtained at revision total hip arthroplasty. J Arthroplasty. 1995; 10: 498-506.
12. Goodman SB, Huie P, Song Y, et al. Cellular profile and cytokine production at prosthetic interfaces. J Bone Joint Surg. 1998; 80B: 531-9.
13. Ishiguro N, Kojima T, Kurokouchi K, et al. mRNA expression of chemokines in interface tissue around loosening total hip arthroplasty components. Trans Orthop Res Soc. 1997; 22: 735.
14. Frokjaer J, Deleuran B, Lind M, et al. Polyethylene particles stimulate monocyte chemotactic and activating factor production in synovial mononuclear cells in vivo. Acta Orthop Scand. 1995; 66: 303-7.
15. Chiba J, Oyama M, Sugawara S, et al. The role of chemokine, adhesion molecules, and cytokine receptor in femoral osteolysis after cementless total hip arthroplasty. Trans Orthop Res Soc. 1996; 21: 514.
16. Rollins BJ. Chemokines. Blood. 1997; 90: 909-28.
17. Nakashima Y, Sun DH, Chun LE, et al. Induction of macrophage C–C chemokine expression by titanium alloy and bone cement particles. J Bone Joint Surg. 1999; 81B: 155-62.
18. Lind M, Trindade M, Nakashima Y, et al. Chemotaxis and activation of particle challenged human monocytes in response to monocyte migration inhibiting factor and C–C chemokines. J Biomed Mat Res. 1999; 48(3): 246-50.
19. Saleh KJ, Thongtrangan I, Schwarz EM. Osteolysis: Medical and surgical approaches. Clin Orthop . 2004; 427: 138-47.
20. Goodman S. Wear particulate and osteolysis. Orthop Clin North Am. 2005; 36(1): 41-8.
21. Jacobs JJ, Roebuck KA, Archibeck M, et al. Osteolysis: Basic science. Clin Orthop. 2001; 393: 71 [39].
22. Archibeck MJ, Jacobs JJ, Roebuck KA, et al. The basic science of periprosthetic osteolysis. Instr Course Lect. 2001; 50: 185-95.
23. Zreiqat H, Crotti TN, Howlett CR, et al. Prosthetic particles modify the expression of bone-related proteins by human osteoblastic cells in vitro. Biomaterials. 2003; 24(2): 337-46.
24. Gutwein LG, Webster TJ. Increased viable osteoblast density in the presence of nanophase compared to conventional alumina and titanium particles. Biomaterials. 2004; 25(18): 4175-83.
25. Fritz EA, Jacobs JJ, Glant TT, et al. Chemokine IL-8 induction by particulate wear debris in osteoblasts is mediated by NF-kB. J Orthop Res. 2005; 23(6): L1249-57.
26. Fritz EA, Glant TT, Vermes C, et al. Chemokine gene activation in human bone marrow-derived osteoblasts following exposure to particulate wear debris. J Biomed Mater Res. 2006; 77(1): 192-201.
27. Goodman SB, Ma T, Chiu R, et al. Effects of orthopaedic wear particles on osteoprogenitor cells. Biomaterials. 2006; 27(36):6096-101.
28. Al-Saffar N, Revell PA. Differential expression of transforming growth factor-alpha and macrophage colony-stimulating factor/colony-stimulating factor-1R (c-fins) by multinucleated giant cells involved in pathological bone resorption at the site of orthopaedic implants. J Orthop Res. 2000; 18(5): 800-7.
29. Itonaga I, Sabokbar A, Murray DW, et al. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages. Ann Rheum Dis. 2000; 59(1): 26-31.
30. Sabokbar A, Kudo O, Athanasou NA. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. J Orthop Res. 2003; 21(1): 73-80.
31. Mandelin J, Li TF, Liljestrom M, Kroon ME, et al. Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. J Bone Joint Surg. 2003; 85B: 1196-201.
32. Crotti TN, Smith MD, Findlay DM, et al. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin. Biomaterials. 2004;25(4):565–73.
33. Takagi M, Konttinen YT, Lindy O, et al. Gelatinase/type IV collagenases in the loosening of total hip replacement endoprostheses. Clin Orthop. 1994; 306: 135-44.
34. Tagaki M, Konttinen YT, Kemppinen P, et al. Tissue inhibitor of metalloproteinase 1, collagenolytic and gelatinolytic activity in loose hip endoprostheses. J Rheumatol. 1995; 22: 2285-90.
35. Takagi M. Neutral proteinases and their inhibitors in the loosening of total hip prostheses. Acta Orthop Scand. 1996; 67(Suppl 271): 1-29.
36. Takagi M, Santavirta S, Ida H, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in loose artificial hip joints. Clin Orthop. 1998; 352: 35-45.
37. Takei I, Takagi M, Santavirta S, et al. Metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial joints. J Biomed Mater Res. 1999; 45: 175-83.
38. Takagi M, Konttinen YT, Santavirta S, et al. Cathepsin G and alph 1-antichymotrypsin in the local host reaction to loosening of total hip prostheses. J Bone Joint Surg. 1995; 77A: 16-25.
39. Takagi M, Konttinen YT, Santavirta S, et al. Elastase activity, uninhibited by alpha 1-antitrypsin, in the periprosthetic connective matrix around loose total hip prostheses. J Orthop Res. 1995; 13(2): 296-304.
40. Li TF, Warris V, Ma J, et al. Distribution of tenascin-X in different synovial samples and synovial membrane-like interface tissue from aseptic loosening of total hip replacement. Rheumatol Int. 2000; 19(5): 177– 83.
41. Li TF, Santavirta S, Virtanen I, et al. Increased expression of EMMPRIN in the tissue around loosened hip prostheses. Acta Orthop Scand. 1999; 70(5): 446 -51.
42. Takagi M, Konttinen YT, Santavirta S, et al. Extracellular matrix metalloproteinases around loose total hip prostheses. Acta Orthop Scand. 1994; 65(4): 281-6.
43. Willert HG, Semlitsch M. Tissue reactions to plastic and metallic wear products of joint endoprostheses. Clin Orthop. 1996; 333:4-14.
44. Willert HG, Bertram H, Buchhorn GH. Osteolysis in alloarthroplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Clin Orthop. 1990; 258: 95-107.
45. Kobayashi A, Freeman MA, Bonfield W, et al. Number of polyethylene particles and osteolysis in total joint replacements. A quantitative study using a tissue-digestion method. J Bone Joint Surg. 1997; 79B: 844-8.
46. Green TR, Fisher J, Matthews JB, et al. Effect of size and dose on bone resorption activity of macrophages by in vitro clinically relevant ultra high molecular weight polyethylene particles. J Biomed Mater Res. 2000; 53(5): 490-7.
47. Haynes DR, Boyle SJ, Rogers SD. Variation in cytokines induced by particles from different prosthetic materials. Clin Orthop. 1998; 352: 223-30.
48. Ramachandran R, Goodman SB, Smith RL. The effects of titanium and polymethylmethacrylate particles on osteoblastic phenotypic stablilty. J Biomed Mater Res. 2006; 77(3): 512-7.
49. Shanbhag AS, Jacobs JJ, Black J, et al. Macrophage/particle interactions: effect of size, composition and surface area. J Biomed Mater Res. 1994; 28(1): 81-90.
50. Yamamoto A, Honma R, Sumita M, et al. Cytotoxicity evaluation of ceramic particles of different sizes and shapes. J Biomed Mater Res. 2004; 68(2): 244-56.
51. Schmalzried TP, Callaghan JJ. Wear in total hip and knee replacements. J Bone Joint Surg. 1999; 81A: 115-36.
52. Skripitz R, Aspenber P. Pressure-induced periprosthetic osteolysis: A rat model. J Orthop Res. 2000; 18: 481-4.
53. Harris WH. Wear and periprosthetic osteolysis: the problem. Clin Orthop. 2001; 393: 66-70.
54. Dunbar MJ, Blacley HR, Bourne RB. Osteolysis of the femur: Principles of management. In Sim [ed]. AAOS Instructional Course lectures 2001; 50: 197-209.
55. Chatoo M, Parfitt J, Pearse MF. Periprosthetic acetabular fracture associated with extensive osteolysis. J Arthroplasty. 1998; 13(7): 843-5.
56. Sánchez-Sotelo J, McGrory BJ, Berry DJ. Acute periprosthetic fracture of the acetabulum associated with osteolytic pelvic lesions: a report of 3 cases. J Arthroplasty. 2000; 15(1): 126-30.
57. Looney RJ, Boyd A, Totterman S, et al. Volumetric computerized tomography as a measurement of periprosthetic acetabular osteolysis and its correlation with wear. Arthritis Res. 2004; 1: 59-63.
58. Puri L, Wixson RL, Stern SH, et al. Use of helical computed tomography for the assessment of acetabular osteolysis after total hip arthroplasty. J Bone Joint Surg. 2002; 84A: 609-14.
59. Stulberg SD, Wixson RL, Adams AD. Monitoring pelvic osteolysis following total hip replacement surgery: an algorithm for surveillance. J Bone Joint Surg. 2002; 84A(Suppl 2): 116-22.
60. Lewis G. Polyethylene wear in total hip and knee arthroplasties. J Biomed Mater Res. 1997; 38(1): 55-75.
61. Bartel DL, Rawlinson JJ, Burstein AH, et al. Stresses in polyethylene components of contemporary total knee replacements. Clin Orthop. 1995317: 76-82; 1995.
62. Sutula LC, Collier JP, Saum KA, et al. Impact of gamma sterilization on clinical performance of polyethylene in the hip. Clin Orthop. 1995; 319: 28-40.
63. Rose RM, Crugnola A, Ries M, et al. On the origins of high in vivo wear rates in polyethylene components of total joint prostheses. Clin Orthop. 1979; 145: 277-86.
64. McKellop HA, Campbell P, Park SH, et al. The origin of submicron polyethylene wear debris in total hip arthroplasty. ClinOrthop. 1995; 311: 3-20.
65. Engh GA, Ammeen D. Polyethylene wear . Clin Orthop. 2002; 404: 71-4.
66. Sychterz CJ, Engh CA, Yang A, et al. Analysis of temporal wear patterns of porous-coated acetabular components: distinguishing between true wear and so-called bedding-in. J Bone Joint Surg. 1999; 81A(6): 821-30.
67. Valstar ER, Vrooman HA, Toksvig-Larsen S, et al. Digital automated RSA compared to manually operated RSA. J Biomech. 2000; 33(12): 1593-9. E
68. Shaver SM, Brown TD, Hillis SL, et al. Digital edge-detection measurement of polyethylene wear after total hip arthroplasty. J Bone Joint Surg. 1997; 79(5): 690-700.
69. Harris WH. Highly cross-linked, electron-beam-irradiated, melted polyethylene: some pros. Clin Orthop. 2004; 429: 63-7.
70. Gordon AC, D'Lima DD, Colwell CW. Highly cross-linked polyethylene in total hip arthroplasty. J Am Acad Orthop Surg. 2006; 14(9): 511-23.
71. Fisher J, McEwen HM, Barnett PI, et al. Influences of sterilising techniques on polyethylene wear. Knee. 2004; 11(3): 173-6.
72. Oral E, Rowell SL, Muratoglu OK. The effect of alpha-tocopherol on the oxidation and free radical decay in irradiated UHMWPE. Biomaterials. 2006; 27(32): 5580-7.
73. Wolf C, Maninger J, Lederer K, et al. Stabilisation of crosslinked ultra-high molecular weight polyethylene (UHMW-PE)-acetabular components with alpha-tocopherol. J Mater Sci Mater Med. 2006; 17(12): 1323-31.
74. Dumbleton JH, D'Antonio JA, Manley MT, et al. The basis for a second-generation highly cross-linked UHMWPE. Clin Orthop. 2006; 453: 265-71.
75. Scholes SC, Unsworth A. The tribology of metal-on-metal total hip replacements. Proc Inst Mech Eng. 2006; 220(2): 183-94.
76. Capello WN, Dantonio JA, Feinberg JR. Alternative bearing surfaces: alumina ceramic bearings for total hip arthroplasty. Instr Course Lect. 2005; 54: 171-6.
77. Goodman SB, Trindade M, Ma T, et al. Pharmacologic modulation of periprosthetic osteolysis. Clin Orthop. 2005; 430: 39-45.
78. Horowitz SM, Algan SA, Purdon MA. Pharmacologic inhibition of particulate-induced bone resorption. J Biomed Mater Res. 1996; 31: 91-6.
79. Huk OL, Zukor DJ, Antoniou, et al. Effect of pamidronate on the stimulation of macrophage TNF-alpha release by ultrahighmolecular-weight polyethylene particles: a role for apoptosis. J OrthopRes. 2003; 21: 81-7.
80. Thadani PJ, Waxman B, Sladek E, et al. Inhibition of particulate debris-induced osteolysis by alendronate in a rat model. Orthopedics. 2002; 25: 59-63.
81. Goodman SB, Chin RC, Chiou SS, et al. Suppression of prostaglandin E2 synthesis in the membrane surrounding particulate polymethylmethacrylate in the rabbit tibia. Clin Orthop. 1991; 271: 300-4.
82. Zhang X, Morham SG, Langenbach R, et al. Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced steolysis. J Bone Miner Res. 2001; 16: 660-70 .
83. Childs LM, Goater JJ, O’Keefe RJ, et al. Efficacy of Etanercept for wear debris-induced osteolysis. J Bone Min Res. 2001; 16:338-47.
84. Childs LM, Goater JJ, O’Keefe RJ, et al. Effect of antitumor necrosis factor-alpha gene therapy on wear debris-induced osteolysis. J Bone Joint Surg. 2001; 83A: 1789-97.
85. Goodman SB, Song Y, Chun L, et al. Effects of TGF beta on bone ingrowth in the presence of polyethylene particles. J Bone Joint Surg. 1999; 81B: 1069-75 .
86. Goodman SB, Song Y, Yoo JY, et al. Local infusion of FGF-2 enhances bone ingrowth in rabbit chambers in the presence of polyethylene particles. J Biomed Mat Res. 2003; 65A: 454-61 .

Reference